They’re Coming for Your DNA
By Emily Bazelon,
Slate
| 06. 03. 2013
DNA analysis is the major crime-solving advance of our time. It’s the science behind many exonerations, and many more guilty pleas. It’s far more accurate than fingerprinting or eyewitness identification. So the more DNA collection, the better, right?
Federal prosecutors and 28 states have answered yes to that question by routinely collecting DNA samples from arrestees. On Monday, the
Supreme Court approved Maryland’s DNA law, ushering in a new era of massive double-helix collection. There are two oddities about the court’s 5-to-4 ruling. The first is that the majority pretended that this decision had little to do with solving crimes. The second is the lineup: The dissent is a smoking Scalia special—and he’s joined by Justices Elena Kagan, Ruth Bader Ginsburg, and Sonia Sotomayor rather than the court’s conservatives. Anthony Kennedy picked off Stephen Breyer (along with Clarence Thomas, Samuel Alito, and John Roberts) to eke out a majority. But it’s Scalia who wins the argument.
Here are the background facts: All 50 states collect DNA from people who have been convicted of crimes, and that’s not what’s at issue...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Sriparna Roy, Reuters | 04.23.2026
The U.S. Food and Drug Administration has approved Regeneron’s gene therapy for a rare genetic form of deafness, the company said on Thursday.
This approval, granted under the FDA’s new priority voucher program, marks the introduction of the first gene...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...